RE:The best of all worldsDoc01. I'm a bit confused by your comment "Cost competitiveness is not the problem at the Canadian plant, it's the limited production capability as evident by the $150 million, or so, sales backlog". Here are a couple of my thoughts. 1) We don't know if cost competiveness is an issue or not. They have never sold production quantities. 2) It's odd that they have limited production facilities in Canada, given their previous statements on the issue and the government grants they have received to increase production capacity 3) I can't remember hearing anywhere about a $150M sales "backlog". I suspect that you mean "pipeline". These two things are really very, very different. Backlog is something that you have already booked and not delivered. Pipeline is your assessment of future opportunity. Given EFL's historical pronouncements about the glorious future opportunities that never materialized, I'd suggest that a careful investor treat these claims with a high degree of circumspection. 4) I don't see how EFL's assessment of the sales "pipeline" is evidence of anything with regard to production capacity. In addition, you make a number of startling claims about the transaction, the subsequent production costs and the profitability of the future contracts executed in the new facility. Can I respectfully suggest that you (along with the rest of us) really haven't got a clue about any of these things and it is all just wishful thinking. Why don't we wait to see if this transaction is capable of being financed and closed, then wait to see what management have to say about their future plans and forecasts rather than just guess at it all on these discussion boards. Personally, I think that things will end up being very, very different from your confident prognosis. I'm not sure that premature and hypothetical commentary on these unknown issues by either of us will be terribly helpful to a thoughtful investor.